Therapeutic procedure Group
Item
group 1: treatment group
boolean
C0087111 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
Postmenopausal state | Breast Carcinoma TNM clinical staging
Item
postmenopausal breast cancer patients (stage 1 and 2)
boolean
C0232970 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Institutionalized Absent
Item
non-institutionalized
boolean
C0562359 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Anastrozole prescribed
Item
prescribed anastrozole within the preceding 1-2 weeks
boolean
C0290883 (UMLS CUI [1,1])
C0278329 (UMLS CUI [1,2])
Ambulatory
Item
ambulatory
boolean
C0439841 (UMLS CUI [1])
Able to read Study Protocol | Able to read Informed Consent | Comprehension Study Protocol | Comprehension Informed Consent
Item
ability to read and comprehend study protocol and informed consent
boolean
C0586740 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0021430 (UMLS CUI [2,2])
C0162340 (UMLS CUI [3,1])
C2348563 (UMLS CUI [3,2])
C0162340 (UMLS CUI [4,1])
C0021430 (UMLS CUI [4,2])
Control Group
Item
group 2: control group
boolean
C0009932 (UMLS CUI [1])
Gender | Healthy | Age matched | Postmenopausal state
Item
healthy, age-matched postmenopausal women
boolean
C0079399 (UMLS CUI [1])
C3898900 (UMLS CUI [2])
C0001779 (UMLS CUI [3,1])
C0150103 (UMLS CUI [3,2])
C0232970 (UMLS CUI [4])
Institutionalized Absent
Item
non-institutionalized
boolean
C0562359 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Ambulatory
Item
ambulatory
boolean
C0439841 (UMLS CUI [1])
Able to read Study Protocol | Able to read Informed Consent | Comprehension Study Protocol | Comprehension Informed Consent
Item
ability to read and comprehend study protocol and informed consent
boolean
C0586740 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0021430 (UMLS CUI [2,2])
C0162340 (UMLS CUI [3,1])
C2348563 (UMLS CUI [3,2])
C0162340 (UMLS CUI [4,1])
C0021430 (UMLS CUI [4,2])
Tamoxifen | Raloxifene
Item
prior tamoxifen or raloxifene therapy
boolean
C0039286 (UMLS CUI [1])
C0244404 (UMLS CUI [2])
Metabolic Bone Disorder Congenital | Osteogenesis Imperfecta
Item
known congenital metabolic bone disease (e.g., osteogenesis imperfecta)
boolean
C0005944 (UMLS CUI [1,1])
C1744681 (UMLS CUI [1,2])
C0029434 (UMLS CUI [2])
Adrenal Cortex Hormones
Item
concomitant treatment with corticosteroids
boolean
C0001617 (UMLS CUI [1])
Endocrine System Diseases | Parathyroidectomy
Item
patients with a history of endocrine disorders or surgical parathyroidectomy
boolean
C0014130 (UMLS CUI [1])
C0079989 (UMLS CUI [2])
Disease Affecting Bone metabolism | Diabetes Mellitus | Lupus Erythematosus, Systemic | Cushing Syndrome | Hyperparathyroidism | Chronic liver disease | Kidney Failure, Chronic | Paget's Disease
Item
patients with disorders known to affect bone metabolism including diabetes mellitus, systemic lupus erythematosus, cushing's disease, hyperparathyroidism, chronic liver disease, chronic renal failure, paget's disease
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0596204 (UMLS CUI [1,3])
C0011849 (UMLS CUI [2])
C0024141 (UMLS CUI [3])
C0010481 (UMLS CUI [4])
C0020502 (UMLS CUI [5])
C0341439 (UMLS CUI [6])
C0022661 (UMLS CUI [7])
C1368019 (UMLS CUI [8])
Condition Preventing Quantitative computed tomography peripheral | Lacking Able to lie quiet Duration
Item
conditions preventing pqct measurement (e.g., unable to lie flat or still for 15 minutes)
boolean
C0348080 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0412669 (UMLS CUI [1,3])
C0205100 (UMLS CUI [1,4])
C0332268 (UMLS CUI [2,1])
C0560841 (UMLS CUI [2,2])
C0439654 (UMLS CUI [2,3])
C0449238 (UMLS CUI [2,4])
Patient unavailable Geographic Follow-up
Item
geographically inaccessible for follow-up
boolean
C1301818 (UMLS CUI [1,1])
C1517526 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])